ACTU
Actuate Therapeutics, Inc. Common stock
NASDAQ: ACTU · HEALTHCARE · BIOTECHNOLOGY
$2.88
-0.69% today
Updated 2026-04-29
Market cap
$68.29M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.06
Dividend yield
—
52W range
$2 – $12
Volume
0.1M
Actuate Therapeutics, Inc. Common stock (ACTU) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 7
Last 7 quarters
Avg EPS surprise
+8.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+45.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+1.3%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.7%
2026-03-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.18 | +25.0% | $2.29 | $2.49 | +8.7% |
| 2025-11-13 | $-0.25 | +10.7% | $6.30 | $5.91 | -6.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.24 | $-0.18 | +25.0% | — | — |
| 2025-09-30 | $-0.28 | $-0.25 | +10.7% | — | — |
| 2025-06-30 | $-0.31 | $-0.30 | +3.2% | — | — |
| 2025-03-31 | $-0.30 | $-0.32 | -6.7% | — | — |
| 2024-12-31 | $-0.29 | $-0.33 | -13.8% | — | — |
| 2024-09-30 | — | $-0.55 | — | — | — |
| 2024-06-30 | — | $-4.20 | — | — | — |
Frequently asked questions
Has Actuate Therapeutics, Inc. Common stock beaten earnings estimates?
Actuate Therapeutics, Inc. Common stock has beaten Wall Street EPS estimates in 3 of its last 7 quarterly reports, with an average EPS surprise of +8.1% over the last 4 quarters.
How does ACTU stock react to earnings?
ACTU stock has moved an average of +1.3% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.